- ►annals.org WA O'Brien, PM Hartigan, ES Daar, MS … - Annals of internal medicine, 1997 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Markers are needed for assessing response to antiretroviral ... Cited by 160 - Related articles - BL Direct - All 4 versions
- ►annals.org MD Hughes, VA Johnson, MS Hirsch, JW Bremer, … - Annals of Internal Medicine, 1997 - Am Coll Physicians Objective: To determine the short-term variability of plasma HIV-1 RNA level
during stable therapy; the relative importance of pretreatment values and early
changes in CD4+ count, HIV-1 RNA levels, and infectious HIV-1 titers in ... Cited by 139 - Related articles - BL Direct - All 4 versions
MD Hughes, VA Johnson, MS Hirsch, JW Bremer, … - Annals of internal medicine, 1997 - ncbi.nlm.nih.gov BACKGROUND: CD4+ lymphocyte counts and plasma HIV-1 RNA levels predict
progression of HIV-related disease, but the relative importance of these and
other virological factors in defining response to antiretroviral therapy is ... Cited by 74 - Related articles
- ►uiowa.edu DA Katzenstein, SM Hammer, MD Hughes, H … - New England Journal of Medicine, 1996 - content.nejm.org Results After eight weeks, the mean (±SE) decrease from base line in the
concentration of HIV RNA, expressed as the change in the base 10 log of the
number of copies per milliliter, was 0.26±0.06 for patients treated with ... Cited by 361 - Related articles - BL Direct - All 7 versions
AM Caliendo - Clinical Microbiology Newsletter, 1997 - Elsevier M. Heath-Chiozzi et al., Anti-HIV activity and lymphocyte surrogate marker
response dynamics to ritonavir therapy in advanced MV immunodeficiency, abstract
LB6b., 3rd Conference on Retroviruses and Opportunistic Infections ... Cited by 16 - Related articles - BL Direct - All 2 versions
JW Mellors, A Munoz, JV Giorgi, JB Margolick, … - Annals of Internal Medicine, 1997 - Am Coll Physicians Background: The rate of disease progression among persons infected with human
immunodeficiency virus type 1 (HIV-1) varies widely, and the relative prognostic
value of markers of disease activity has not been defined. Cited by 1351 - Related articles - BL Direct - All 6 versions
[CITATION] Concise Review for Primary-Care Physicians
WA O'Brien, PM Hartigan, D Martin, J Esinhart … - The New England journal of medicine, 1996 - nejm.highwire.org Results Among the 129 patients in the immediate-treatment group, 34 had disease
that progressed to AIDS, as compared with 57 of the 141 patients in the
deferred-treatment group (P = 0.03). Progression to AIDS correlated ... Cited by 589 - Related articles - BL Direct - All 5 versions
- ►nih.gov [PDF] EJ Erbelding, TC Quinn - Genitourinary Medicine, 1996 - pubmedcentral.nih.gov Molecular techniques that quantify and detect circulating HIV RNA have led to a
new understanding of the patho- genesis of HIV disease and a new surrogate
marker for use in clinical management. Prior to theability to quantify ... Cited by 4 - Related articles - BL Direct - All 5 versions
A Soennerborg - LAKARTIDNINGEN, 1997 - ltarkiv.lakartidningen.se Mätning av mängden humant im- munbristvirus typ 1-RNA i plasma kan nu utföras
rutinmässigt med nya mole- kylärbiologiska metoder. Genom att an- vända dessa
test för studier av virusom- sättningen i samband med behandling med nya ... Related articles - View as HTML - BL Direct
